Dosidal · South Korea
한불베타메타손정(베타메타손)0.5mg
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | South Korea |
|---|---|
| Record | kr:presentation:kd:8806562024902 (version 1) |
| Level | presentation |
| Pack code | gtin: 08806562024902 |
| Identifiers | gtin: 08806562024902 kr-standard-code: 8806562024902 kr-mfds-item: 199902781 |
| Source authority | HIRA / MFDS |
| Read date | 2026-11-15T05:00:21Z |
| authorisation status | cancelled_on: 2020-09-02 lifecycle: history note: HIRA standard-code mapping status; MFDS authorisation status not read state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| controlled status | category: 해당사항없음 controlled: False state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| identity | atc: H02AB01 company: (주)바스칸바이오제약 ingredient_code: 116401ATB item_approval_date: 1999-05-27 marking: 바코드 mfds_item_code: 199902781 product_name: 한불베타메타손정(베타메타손)0.5mg serial_number_omitted: N spec: 0.5밀리그램 standard_code: 8806562024902 total_quantity: 0 state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| pack product code | check_digit_ok: True gtin: 08806562024902 published_by: HIRA representative_code: 8806562024902 standard_code: 8806562024902 state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| prescription class | as_published: 전문의약품 class: prescription state: current · read 2026-11-15T05:00:21Z · source: 건강보험심사평가원 (HIRA) - 의약품표준코드, via data.go.kr page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53O0ArciEFpYGcBZg7nKYVIRsH2VSjly4_MVakMreEQHs7lOruiHmFEDoKaX83by5eko1Z_vBfFMEQ5FS7uR_x9wVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/kr:presentation:kd:8806562024902 · Same medicine in other markets · Dosidal